QQ客服 官方微博 反馈留言

	A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA
	Yin, Feng[1]; Yang, Chengbin[1]; Wang, Qianqian[3]; Zeng, Shuwen[1,8]; Hu, Rui[1]; Lin, Guimiao[6,7]; Tian, Jinglin[6,7]; Hu, Siyi[9]; Lan, Rong Feng[10]; Yoon, Ho Sup[2,11]
刊名	THERANOSTICS
	2015
卷号	5页码:818-833
关键词	AuNRs siRNA K-Ras Doxorubicin Pancreatic adenocarcinoma tumors
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2210939
专题	华南理工大学
作者单位	1.[1]Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore 2.[2]Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore 3.[3]Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genet, Shenzhen 518055, Peoples R China 4.[4]Acad Sinica, Nanomed Program, Taipei 115, Taiwan 5.[5]Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan 6.[6]Shenzhen Univ, Sch Med Sci, Key Lab Biomed Engn, Shenzhen 518060, Peoples R China 7.[7]Shenzhen Univ, Sch Med Sci, Res Inst Uropoiesis & Reprod, Shenzhen 518060, Peoples R China 8.[8]CINTRA CNRS NTU THALES, UMI 3288, Singapore 637553, Singapore 9.[9]Changchun Univ Sci & Technol, Sch Sci, Changchun 130022, Peoples R China 10.[10]Hong Kong Baptist Univ Shenzhen, Inst Res & Continuing Educ, Shenzhen 518057, Peoples R China
推荐引用方式 GB/T 7714	Yin, Feng[1],Yang, Chengbin[1],Wang, Qianqian[3],et al. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA[J]. THERANOSTICS,2015,5:818-833.
APA	Yin, Feng[1].,Yang, Chengbin[1].,Wang, Qianqian[3].,Zeng, Shuwen[1,8].,Hu, Rui[1].,...&Yong, Ken-Tye[1].(2015).A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.THERANOSTICS,5,818-833.
MLA	Yin, Feng[1],et al."A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA".THERANOSTICS 5(2015):818-833.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。